» Articles » PMID: 21700211

Development of Neh2-luciferase Reporter and Its Application for High Throughput Screening and Real-time Monitoring of Nrf2 Activators

Overview
Journal Chem Biol
Publisher Elsevier
Date 2011 Jun 25
PMID 21700211
Citations 58
Authors
Affiliations
Soon will be listed here.
Abstract

The NF-E2-related factor 2 (Nrf2) is a key transcriptional regulator of antioxidant defense and detoxification. To directly monitor stabilization of Nrf2, we fused its Neh2 domain, responsible for the interaction with its nucleocytoplasmic regulator, Keap1, to firefly luciferase (Neh2-luciferase). We show that Neh2 domain is sufficient for recognition, ubiquitination, and proteasomal degradation of Neh2-luciferase fusion protein. The Neh2-luc reporter system allows direct monitoring of the adaptive response to redox stress and classification of drugs based on the time course of reporter activation. The reporter was used to screen the Spectrum library of 2000 biologically active compounds to identify activators of Nrf2. The most robust and yet nontoxic Nrf2 activators found--nordihydroguaiaretic acid, fisetin, and gedunin--induced astrocyte-dependent neuroprotection from oxidative stress via an Nrf2-dependent mechanism.

Citing Articles

A Novel Analog of the Natural Product Fraxinellone Protects against Endogenous and Exogenous Neurotoxicants.

Bartman A, Raeisi M, Peiris C, Jacobsen I, Martin D, Doorn J ACS Chem Neurosci. 2024; 15(14):2612-2622.

PMID: 38925635 PMC: 11258694. DOI: 10.1021/acschemneuro.4c00090.


Therapeutic Role of Chinese Medicine Targeting Nrf2/HO-1 Signaling Pathway in Myocardial Ischemia/Reperfusion Injury.

Liu C, Guo X, Zhou Y, Wang H Chin J Integr Med. 2024; 30(10):949-960.

PMID: 38329655 DOI: 10.1007/s11655-024-3657-0.


Azadiradione, a Component of Neem Oil, Behaves as a Superoxide Dismutase Mimic When Scavenging the Superoxide Radical, as Shown Using DFT and Hydrodynamic Voltammetry.

Sakib R, Caruso F, Belli S, Rossi M Biomedicines. 2023; 11(11).

PMID: 38002091 PMC: 10669394. DOI: 10.3390/biomedicines11113091.


Emerging small molecule inhibitors of Bach1 as therapeutic agents: Rationale, recent advances, and future perspectives.

Hushpulian D, Kaidery N, Dutta D, Sharma S, Gazaryan I, Thomas B Bioessays. 2023; 46(1):e2300176.

PMID: 37919861 PMC: 11260292. DOI: 10.1002/bies.202300176.


CRISPR/Cas9-Based Screening of FDA-Approved Drugs for NRF2 Activation: A Novel Approach to Discover Therapeutics for Non-Alcoholic Fatty Liver Disease.

Li J, Arest S, Olszowy B, Gordon J, Barrero C, Perez-Leal O Antioxidants (Basel). 2023; 12(7).

PMID: 37507903 PMC: 10375998. DOI: 10.3390/antiox12071363.


References
1.
Calabrese V, Cornelius C, Mancuso C, Pennisi G, Calafato S, Bellia F . Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity. Neurochem Res. 2008; 33(12):2444-71. DOI: 10.1007/s11064-008-9775-9. View

2.
Safran M, Kim W, OConnell F, Flippin L, Gunzler V, Horner J . Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: assessment of an oral agent that stimulates erythropoietin production. Proc Natl Acad Sci U S A. 2005; 103(1):105-10. PMC: 1324998. DOI: 10.1073/pnas.0509459103. View

3.
Zhang T, Li Y, Yu Y, Zou P, Jiang Y, Sun D . Characterization of celastrol to inhibit hsp90 and cdc37 interaction. J Biol Chem. 2009; 284(51):35381-9. PMC: 2790967. DOI: 10.1074/jbc.M109.051532. View

4.
Yates M, Tauchi M, Katsuoka F, Flanders K, Liby K, Honda T . Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes. Mol Cancer Ther. 2007; 6(1):154-62. DOI: 10.1158/1535-7163.MCT-06-0516. View

5.
Shih A, Li P, Murphy T . A small-molecule-inducible Nrf2-mediated antioxidant response provides effective prophylaxis against cerebral ischemia in vivo. J Neurosci. 2005; 25(44):10321-35. PMC: 6725780. DOI: 10.1523/JNEUROSCI.4014-05.2005. View